非综合征性感官神经性听力损失伴MYO15A突变患者的特点与预后
回顾性分析14个家系16例MYO15A突变致聋患者,携带5种既往未报道突变,3例见内耳畸形。人工耳蜗植入者术后1年听力言语显著改善,助听器使用者4年内呈渐进改善趋势;双侧耳蜗孔闭锁者早期植入亦获满意效果。
要点
- MYO15A突变患者中检出5种既往未报道突变,3例伴内耳畸形。
- 人工耳蜗植入者术后1年听力与言语能力显著改善。
- 助听器使用者在4年观察期内呈渐进改善趋势。
核心结论
- 携带MYO15A突变并接受人工耳蜗植入的患者,其听力与言语发育改善通常早于使用助听器的患者。
- 作者建议进行早期基因检测并及时实施助听声刺激以获得最佳效果。
研究设计与样本
- 回顾性病例复习,纳入14个无亲缘关系家系的16例MYO15A突变致聋患者。
- 通过测序招募潜在致病性MYO15A突变致听力损失患者,结合基因型分析听力学数据、影像学及不同治疗前后的听力言语表现。
主要发现
- 检出5种既往未报道突变:c.3660_3666delinsAA(p.Glu1221fs)、c.4635delG(p.Val1545fs)、c.6664A>G(p.Met2222Val)、c.8215delG(p.Ala2739fs)和c.8897delG(p.Gly2966fs)。
- 3例患者观察到内耳畸形。
- 人工耳蜗植入者术后1年听力与言语能力显著改善,助听器使用者在4年期间呈渐进改善趋势。
- 双侧耳蜗孔闭锁患者早期行人工耳蜗植入后亦获得满意的听力与言语结果。
临床怎么用
- 作者建议对MYO15A突变相关听力损失进行早期基因检测,并及时实施助听声刺激以获最佳效果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aims to investigate the characteristics of hearing loss associated with MYO15A mutations and to analyze the longitudinal prognosis over a 4-year period using different treatment modalities, including cochlear implants (CIs), hearing aids (HAs), and conservative management. STUDY DESIGN: A retrospective case review. SETTING: A tertiary referral center. METHODS: Sequencing was performed to recruit patients with potentially pathogenic MYO15A mutation-induced hearing loss. Audiological data, radiological imaging, and assessment of hearing and speech performance before and after different treatments were analyzed in combination with patients' genotypes. RESULTS: Sixteen patients with MYO15A mutation-induced deafness from 14 unrelated pedigrees were enrolled, carrying 5 previously unreported mutations: c.3660_3666delinsAA (p.Glu1221fs), c.4635delG (p.Val1545fs), c.6664A>G (p.Met2222Val), c.8215delG (p.Ala2739fs), and c.8897delG (p.Gly2966fs). Inner ear malformations were observed in 3 patients. CI recipients exhibited significant improvements in hearing and speech abilities 1-year post-implantation, while individuals using HAs showed a gradual improvement trend over a 4-year period. Notably, even those with bilateral cochlear aperture atresia achieved satisfactory hearing and speech outcomes following early CIs. CONCLUSION: Patients with MYO15A mutations who underwent CIs generally demonstrated earlier improvements in hearing and speech development compared to those using HAs. Early genetic detection and timely implementation of assistive acoustic stimulation are recommended for optimal outcomes.
引用
- Wang Y, Fang S, Cen X, et al. Characteristics and Prognosis of Patients With Non-Syndromic Sensorineural Hearing Loss Associated With Myo15a Mutations. Otolaryngol Head Neck Surg. 2025. PMID: 40052343. doi:10.1002/ohn.1200
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。